Trial Profile
A study comparing efficacies of Naftopidil and Tamsulosin in terms of reducing storage symptoms in patients with benign prostatic hyperplasia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2017
Price :
$35
*
At a glance
- Drugs Naftopidil (Primary) ; Tamsulosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 29 Nov 2017 New trial record